| |
Number |
Median |
Range |
| Men |
12 (75%) |
|
|
| Ethnicity |
|
|
|
| Caucasian |
12 (75%) |
|
|
| Black African |
4 (25%) |
|
|
| Risk-factor |
|
|
|
| Heterosexual |
8 (50%) |
|
|
| MSM |
3 (19%) |
|
|
| Other |
5 (31%) |
|
|
| Age at diagnosis (years) |
|
38 |
23-65 |
| Age at death (years) |
|
46.50 |
31-80 |
| Time from diagnosis to death (years) |
|
4.20 |
0.04-17.82 |
| CD4 at diagnosis (cells/microL) |
|
38 |
9-400 |
| CD4 at death (cells/microL) |
|
44 |
2-475 |
| VL at diagnosis (copies/L) |
|
190 00 |
23 300-340 000 |
| VL at death (copies/L) |
|
100 000 |
0-1.9 x 106 |
|
